nodes	percent_of_prediction	percent_of_DWPC	metapath
Levorphanol—Hypoxia—Gemcitabine—pancreatic cancer	0.0082	0.0196	CcSEcCtD
Levorphanol—Hypokinesia—Irinotecan—pancreatic cancer	0.00792	0.019	CcSEcCtD
Levorphanol—Respiratory failure—Sunitinib—pancreatic cancer	0.00661	0.0158	CcSEcCtD
Levorphanol—Respiratory failure—Gemcitabine—pancreatic cancer	0.0053	0.0127	CcSEcCtD
Levorphanol—Mood swings—Tamoxifen—pancreatic cancer	0.00521	0.0125	CcSEcCtD
Levorphanol—Injection site reaction—Gemcitabine—pancreatic cancer	0.00518	0.0124	CcSEcCtD
Levorphanol—Coma—Fluorouracil—pancreatic cancer	0.00468	0.0112	CcSEcCtD
Levorphanol—Renal failure—Erlotinib—pancreatic cancer	0.00412	0.00987	CcSEcCtD
Levorphanol—Sweating—Tamoxifen—pancreatic cancer	0.00407	0.00973	CcSEcCtD
Levorphanol—Amnesia—Fluorouracil—pancreatic cancer	0.00396	0.00947	CcSEcCtD
Levorphanol—Lethargy—Fluorouracil—pancreatic cancer	0.00379	0.00908	CcSEcCtD
Levorphanol—Respiratory failure—Docetaxel—pancreatic cancer	0.00376	0.00901	CcSEcCtD
Levorphanol—Hypokinesia—Epirubicin—pancreatic cancer	0.00369	0.00884	CcSEcCtD
Levorphanol—Cardiac arrest—Irinotecan—pancreatic cancer	0.00369	0.00884	CcSEcCtD
Levorphanol—Injection site reaction—Docetaxel—pancreatic cancer	0.00368	0.0088	CcSEcCtD
Levorphanol—Visual impairment—Tamoxifen—pancreatic cancer	0.00367	0.00878	CcSEcCtD
Levorphanol—Renal failure—Sunitinib—pancreatic cancer	0.00357	0.00855	CcSEcCtD
Levorphanol—Cardiac arrest—Fluorouracil—pancreatic cancer	0.00354	0.00846	CcSEcCtD
Levorphanol—Flushing—Tamoxifen—pancreatic cancer	0.00353	0.00846	CcSEcCtD
Levorphanol—Hypokinesia—Doxorubicin—pancreatic cancer	0.00342	0.00818	CcSEcCtD
Levorphanol—Arrhythmia—Tamoxifen—pancreatic cancer	0.0034	0.00814	CcSEcCtD
Levorphanol—Arrhythmia—Erlotinib—pancreatic cancer	0.00336	0.00806	CcSEcCtD
Levorphanol—Bradycardia—Sunitinib—pancreatic cancer	0.00332	0.00795	CcSEcCtD
Levorphanol—Muscle spasms—Tamoxifen—pancreatic cancer	0.00319	0.00763	CcSEcCtD
Levorphanol—Flushing—Sunitinib—pancreatic cancer	0.00303	0.00724	CcSEcCtD
Levorphanol—Renal failure—Irinotecan—pancreatic cancer	0.00294	0.00704	CcSEcCtD
Levorphanol—Arrhythmia—Sunitinib—pancreatic cancer	0.00291	0.00697	CcSEcCtD
Levorphanol—Sweating—Irinotecan—pancreatic cancer	0.00287	0.00687	CcSEcCtD
Levorphanol—Renal failure—Gemcitabine—pancreatic cancer	0.00286	0.00686	CcSEcCtD
Levorphanol—Sweating—Gemcitabine—pancreatic cancer	0.00279	0.00669	CcSEcCtD
Levorphanol—Dry mouth—Tamoxifen—pancreatic cancer	0.00276	0.00661	CcSEcCtD
Levorphanol—Lethargy—Docetaxel—pancreatic cancer	0.00274	0.00656	CcSEcCtD
Levorphanol—Bradycardia—Irinotecan—pancreatic cancer	0.00273	0.00655	CcSEcCtD
Levorphanol—Muscle spasms—Sunitinib—pancreatic cancer	0.00273	0.00653	CcSEcCtD
Levorphanol—Thinking abnormal—Epirubicin—pancreatic cancer	0.00272	0.00652	CcSEcCtD
Levorphanol—Dyskinesia—Epirubicin—pancreatic cancer	0.00265	0.00635	CcSEcCtD
Levorphanol—Shock—Erlotinib—pancreatic cancer	0.00263	0.0063	CcSEcCtD
Levorphanol—Hyperhidrosis—Tamoxifen—pancreatic cancer	0.00261	0.00626	CcSEcCtD
Levorphanol—Visual impairment—Irinotecan—pancreatic cancer	0.00259	0.0062	CcSEcCtD
Levorphanol—Thinking abnormal—Doxorubicin—pancreatic cancer	0.00252	0.00603	CcSEcCtD
Levorphanol—Flushing—Irinotecan—pancreatic cancer	0.00249	0.00597	CcSEcCtD
Levorphanol—Injection site reaction—Epirubicin—pancreatic cancer	0.00248	0.00594	CcSEcCtD
Levorphanol—Abnormal dreams—Epirubicin—pancreatic cancer	0.00246	0.0059	CcSEcCtD
Levorphanol—Convulsion—Sunitinib—pancreatic cancer	0.00246	0.00589	CcSEcCtD
Levorphanol—Dyskinesia—Doxorubicin—pancreatic cancer	0.00245	0.00588	CcSEcCtD
Levorphanol—Insomnia—Tamoxifen—pancreatic cancer	0.00245	0.00586	CcSEcCtD
Levorphanol—Insomnia—Erlotinib—pancreatic cancer	0.00242	0.00579	CcSEcCtD
Levorphanol—Arrhythmia—Irinotecan—pancreatic cancer	0.0024	0.00574	CcSEcCtD
Levorphanol—Dyspepsia—Tamoxifen—pancreatic cancer	0.00238	0.0057	CcSEcCtD
Levorphanol—Dry mouth—Sunitinib—pancreatic cancer	0.00236	0.00566	CcSEcCtD
Levorphanol—Dyspepsia—Erlotinib—pancreatic cancer	0.00236	0.00564	CcSEcCtD
Levorphanol—Arrhythmia—Gemcitabine—pancreatic cancer	0.00234	0.0056	CcSEcCtD
Levorphanol—Constipation—Tamoxifen—pancreatic cancer	0.00231	0.00554	CcSEcCtD
Levorphanol—Arrhythmia—Fluorouracil—pancreatic cancer	0.0023	0.0055	CcSEcCtD
Levorphanol—Injection site reaction—Doxorubicin—pancreatic cancer	0.00229	0.00549	CcSEcCtD
Levorphanol—Constipation—Erlotinib—pancreatic cancer	0.00229	0.00548	CcSEcCtD
Levorphanol—Abnormal dreams—Doxorubicin—pancreatic cancer	0.00228	0.00546	CcSEcCtD
Levorphanol—Shock—Sunitinib—pancreatic cancer	0.00228	0.00546	CcSEcCtD
Levorphanol—Coma—Epirubicin—pancreatic cancer	0.00228	0.00546	CcSEcCtD
Levorphanol—Muscle spasms—Irinotecan—pancreatic cancer	0.00225	0.00538	CcSEcCtD
Levorphanol—Gastrointestinal pain—Tamoxifen—pancreatic cancer	0.00221	0.00529	CcSEcCtD
Levorphanol—Gastrointestinal pain—Erlotinib—pancreatic cancer	0.00219	0.00524	CcSEcCtD
Levorphanol—Abnormal vision—Epirubicin—pancreatic cancer	0.00217	0.00521	CcSEcCtD
Levorphanol—Mental disability—Epirubicin—pancreatic cancer	0.00216	0.00518	CcSEcCtD
Levorphanol—Urticaria—Tamoxifen—pancreatic cancer	0.00215	0.00514	CcSEcCtD
Levorphanol—Abdominal pain—Tamoxifen—pancreatic cancer	0.00214	0.00512	CcSEcCtD
Levorphanol—Abdominal pain—Erlotinib—pancreatic cancer	0.00212	0.00506	CcSEcCtD
Levorphanol—Coma—Doxorubicin—pancreatic cancer	0.00211	0.00505	CcSEcCtD
Levorphanol—Insomnia—Sunitinib—pancreatic cancer	0.00209	0.00502	CcSEcCtD
Levorphanol—Dyspepsia—Sunitinib—pancreatic cancer	0.00204	0.00488	CcSEcCtD
Levorphanol—Renal failure—Docetaxel—pancreatic cancer	0.00203	0.00487	CcSEcCtD
Levorphanol—Abnormal vision—Doxorubicin—pancreatic cancer	0.00201	0.00482	CcSEcCtD
Levorphanol—Mental disability—Doxorubicin—pancreatic cancer	0.002	0.00479	CcSEcCtD
Levorphanol—Constipation—Sunitinib—pancreatic cancer	0.00198	0.00474	CcSEcCtD
Levorphanol—Convulsion—Fluorouracil—pancreatic cancer	0.00194	0.00464	CcSEcCtD
Levorphanol—Confusional state—Irinotecan—pancreatic cancer	0.00192	0.00461	CcSEcCtD
Levorphanol—Pruritus—Tamoxifen—pancreatic cancer	0.00191	0.00458	CcSEcCtD
Levorphanol—Gastrointestinal pain—Sunitinib—pancreatic cancer	0.00189	0.00453	CcSEcCtD
Levorphanol—Pruritus—Erlotinib—pancreatic cancer	0.00189	0.00453	CcSEcCtD
Levorphanol—Shock—Irinotecan—pancreatic cancer	0.00188	0.00449	CcSEcCtD
Levorphanol—Lethargy—Epirubicin—pancreatic cancer	0.00185	0.00442	CcSEcCtD
Levorphanol—Hyperhidrosis—Irinotecan—pancreatic cancer	0.00184	0.00442	CcSEcCtD
Levorphanol—Confusional state—Fluorouracil—pancreatic cancer	0.00184	0.00441	CcSEcCtD
Levorphanol—Abdominal pain—Sunitinib—pancreatic cancer	0.00183	0.00438	CcSEcCtD
Levorphanol—Diplopia—Epirubicin—pancreatic cancer	0.00181	0.00433	CcSEcCtD
Levorphanol—Hyperhidrosis—Gemcitabine—pancreatic cancer	0.0018	0.0043	CcSEcCtD
Levorphanol—Visual impairment—Docetaxel—pancreatic cancer	0.00179	0.00428	CcSEcCtD
Levorphanol—Dizziness—Tamoxifen—pancreatic cancer	0.00179	0.00428	CcSEcCtD
Levorphanol—Tachycardia—Fluorouracil—pancreatic cancer	0.00178	0.00427	CcSEcCtD
Levorphanol—Hypotension—Irinotecan—pancreatic cancer	0.00178	0.00427	CcSEcCtD
Levorphanol—Affect lability—Epirubicin—pancreatic cancer	0.00178	0.00427	CcSEcCtD
Levorphanol—Dizziness—Erlotinib—pancreatic cancer	0.00177	0.00424	CcSEcCtD
Levorphanol—Hypotension—Gemcitabine—pancreatic cancer	0.00174	0.00416	CcSEcCtD
Levorphanol—Insomnia—Irinotecan—pancreatic cancer	0.00173	0.00413	CcSEcCtD
Levorphanol—Flushing—Docetaxel—pancreatic cancer	0.00172	0.00413	CcSEcCtD
Levorphanol—Cardiac arrest—Epirubicin—pancreatic cancer	0.00172	0.00412	CcSEcCtD
Levorphanol—Vomiting—Tamoxifen—pancreatic cancer	0.00172	0.00412	CcSEcCtD
Levorphanol—Mood swings—Epirubicin—pancreatic cancer	0.00171	0.00411	CcSEcCtD
Levorphanol—Lethargy—Doxorubicin—pancreatic cancer	0.00171	0.00409	CcSEcCtD
Levorphanol—Hypotension—Fluorouracil—pancreatic cancer	0.00171	0.00409	CcSEcCtD
Levorphanol—Rash—Tamoxifen—pancreatic cancer	0.00171	0.00408	CcSEcCtD
Levorphanol—Dermatitis—Tamoxifen—pancreatic cancer	0.0017	0.00408	CcSEcCtD
Levorphanol—Vomiting—Erlotinib—pancreatic cancer	0.0017	0.00407	CcSEcCtD
Levorphanol—Rash—Erlotinib—pancreatic cancer	0.00169	0.00404	CcSEcCtD
Levorphanol—Dermatitis—Erlotinib—pancreatic cancer	0.00169	0.00404	CcSEcCtD
Levorphanol—Insomnia—Gemcitabine—pancreatic cancer	0.00168	0.00402	CcSEcCtD
Levorphanol—Dyspepsia—Irinotecan—pancreatic cancer	0.00168	0.00402	CcSEcCtD
Levorphanol—Diplopia—Doxorubicin—pancreatic cancer	0.00167	0.00401	CcSEcCtD
Levorphanol—Arrhythmia—Docetaxel—pancreatic cancer	0.00166	0.00397	CcSEcCtD
Levorphanol—Insomnia—Fluorouracil—pancreatic cancer	0.00165	0.00396	CcSEcCtD
Levorphanol—Affect lability—Doxorubicin—pancreatic cancer	0.00165	0.00395	CcSEcCtD
Levorphanol—Pruritus—Sunitinib—pancreatic cancer	0.00164	0.00392	CcSEcCtD
Levorphanol—Constipation—Irinotecan—pancreatic cancer	0.00163	0.00391	CcSEcCtD
Levorphanol—Dyspepsia—Fluorouracil—pancreatic cancer	0.00161	0.00385	CcSEcCtD
Levorphanol—Nausea—Tamoxifen—pancreatic cancer	0.00161	0.00385	CcSEcCtD
Levorphanol—Cardiac arrest—Doxorubicin—pancreatic cancer	0.00159	0.00381	CcSEcCtD
Levorphanol—Constipation—Gemcitabine—pancreatic cancer	0.00159	0.00381	CcSEcCtD
Levorphanol—Nausea—Erlotinib—pancreatic cancer	0.00159	0.00381	CcSEcCtD
Levorphanol—Mood swings—Doxorubicin—pancreatic cancer	0.00159	0.0038	CcSEcCtD
Levorphanol—Feeling abnormal—Irinotecan—pancreatic cancer	0.00157	0.00376	CcSEcCtD
Levorphanol—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.00156	0.00374	CcSEcCtD
Levorphanol—Muscle spasms—Docetaxel—pancreatic cancer	0.00155	0.00372	CcSEcCtD
Levorphanol—Dizziness—Sunitinib—pancreatic cancer	0.00153	0.00367	CcSEcCtD
Levorphanol—Feeling abnormal—Gemcitabine—pancreatic cancer	0.00153	0.00367	CcSEcCtD
Levorphanol—Abdominal pain—Irinotecan—pancreatic cancer	0.00151	0.00361	CcSEcCtD
Levorphanol—Feeling abnormal—Fluorouracil—pancreatic cancer	0.00151	0.00361	CcSEcCtD
Levorphanol—Vomiting—Sunitinib—pancreatic cancer	0.00147	0.00353	CcSEcCtD
Levorphanol—Dysuria—Epirubicin—pancreatic cancer	0.00146	0.0035	CcSEcCtD
Levorphanol—Rash—Sunitinib—pancreatic cancer	0.00146	0.0035	CcSEcCtD
Levorphanol—Dermatitis—Sunitinib—pancreatic cancer	0.00146	0.00349	CcSEcCtD
Levorphanol—Urticaria—Fluorouracil—pancreatic cancer	0.00145	0.00348	CcSEcCtD
Levorphanol—Palpitations—Docetaxel—pancreatic cancer	0.00143	0.00342	CcSEcCtD
Levorphanol—Convulsion—Docetaxel—pancreatic cancer	0.0014	0.00335	CcSEcCtD
Levorphanol—Nausea—Sunitinib—pancreatic cancer	0.00138	0.00329	CcSEcCtD
Levorphanol—Renal failure—Epirubicin—pancreatic cancer	0.00137	0.00328	CcSEcCtD
Levorphanol—Dysuria—Doxorubicin—pancreatic cancer	0.00135	0.00324	CcSEcCtD
Levorphanol—Dry mouth—Docetaxel—pancreatic cancer	0.00135	0.00322	CcSEcCtD
Levorphanol—Sweating—Epirubicin—pancreatic cancer	0.00134	0.0032	CcSEcCtD
Levorphanol—Confusional state—Docetaxel—pancreatic cancer	0.00133	0.00318	CcSEcCtD
Levorphanol—Pruritus—Gemcitabine—pancreatic cancer	0.00131	0.00315	CcSEcCtD
Levorphanol—Shock—Docetaxel—pancreatic cancer	0.0013	0.00311	CcSEcCtD
Levorphanol—Pruritus—Fluorouracil—pancreatic cancer	0.00129	0.0031	CcSEcCtD
Levorphanol—Tachycardia—Docetaxel—pancreatic cancer	0.00129	0.00308	CcSEcCtD
Levorphanol—Bradycardia—Epirubicin—pancreatic cancer	0.00127	0.00305	CcSEcCtD
Levorphanol—Renal failure—Doxorubicin—pancreatic cancer	0.00127	0.00304	CcSEcCtD
Levorphanol—Dizziness—Irinotecan—pancreatic cancer	0.00126	0.00302	CcSEcCtD
Levorphanol—Sweating—Doxorubicin—pancreatic cancer	0.00124	0.00296	CcSEcCtD
Levorphanol—Hypotension—Docetaxel—pancreatic cancer	0.00123	0.00295	CcSEcCtD
Levorphanol—Vomiting—Irinotecan—pancreatic cancer	0.00121	0.0029	CcSEcCtD
Levorphanol—Dizziness—Fluorouracil—pancreatic cancer	0.00121	0.00289	CcSEcCtD
Levorphanol—Visual impairment—Epirubicin—pancreatic cancer	0.00121	0.00289	CcSEcCtD
Levorphanol—Rash—Irinotecan—pancreatic cancer	0.0012	0.00288	CcSEcCtD
Levorphanol—Dermatitis—Irinotecan—pancreatic cancer	0.0012	0.00288	CcSEcCtD
Levorphanol—Insomnia—Docetaxel—pancreatic cancer	0.00119	0.00286	CcSEcCtD
Levorphanol—Vomiting—Gemcitabine—pancreatic cancer	0.00118	0.00283	CcSEcCtD
Levorphanol—Bradycardia—Doxorubicin—pancreatic cancer	0.00118	0.00282	CcSEcCtD
Levorphanol—Rash—Gemcitabine—pancreatic cancer	0.00117	0.00281	CcSEcCtD
Levorphanol—Dermatitis—Gemcitabine—pancreatic cancer	0.00117	0.0028	CcSEcCtD
Levorphanol—Flushing—Epirubicin—pancreatic cancer	0.00116	0.00278	CcSEcCtD
Levorphanol—Vomiting—Fluorouracil—pancreatic cancer	0.00116	0.00278	CcSEcCtD
Levorphanol—Dyspepsia—Docetaxel—pancreatic cancer	0.00116	0.00278	CcSEcCtD
Levorphanol—Rash—Fluorouracil—pancreatic cancer	0.00115	0.00276	CcSEcCtD
Levorphanol—Dermatitis—Fluorouracil—pancreatic cancer	0.00115	0.00276	CcSEcCtD
Levorphanol—Nausea—Irinotecan—pancreatic cancer	0.00113	0.00271	CcSEcCtD
Levorphanol—Constipation—Docetaxel—pancreatic cancer	0.00113	0.0027	CcSEcCtD
Levorphanol—Arrhythmia—Epirubicin—pancreatic cancer	0.00112	0.00268	CcSEcCtD
Levorphanol—Visual impairment—Doxorubicin—pancreatic cancer	0.00112	0.00267	CcSEcCtD
Levorphanol—Nausea—Gemcitabine—pancreatic cancer	0.0011	0.00264	CcSEcCtD
Levorphanol—Feeling abnormal—Docetaxel—pancreatic cancer	0.00109	0.0026	CcSEcCtD
Levorphanol—Nausea—Fluorouracil—pancreatic cancer	0.00109	0.0026	CcSEcCtD
Levorphanol—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.00108	0.00258	CcSEcCtD
Levorphanol—Flushing—Doxorubicin—pancreatic cancer	0.00108	0.00257	CcSEcCtD
Levorphanol—Tension—Epirubicin—pancreatic cancer	0.00107	0.00256	CcSEcCtD
Levorphanol—Nervousness—Epirubicin—pancreatic cancer	0.00106	0.00253	CcSEcCtD
Levorphanol—Muscle spasms—Epirubicin—pancreatic cancer	0.00105	0.00251	CcSEcCtD
Levorphanol—Abdominal pain—Docetaxel—pancreatic cancer	0.00104	0.0025	CcSEcCtD
Levorphanol—Arrhythmia—Doxorubicin—pancreatic cancer	0.00104	0.00248	CcSEcCtD
Levorphanol—Agitation—Epirubicin—pancreatic cancer	0.001	0.0024	CcSEcCtD
Levorphanol—Tension—Doxorubicin—pancreatic cancer	0.00099	0.00237	CcSEcCtD
Levorphanol—Nervousness—Doxorubicin—pancreatic cancer	0.00098	0.00235	CcSEcCtD
Levorphanol—Muscle spasms—Doxorubicin—pancreatic cancer	0.00097	0.00232	CcSEcCtD
Levorphanol—Palpitations—Epirubicin—pancreatic cancer	0.000963	0.00231	CcSEcCtD
Levorphanol—Convulsion—Epirubicin—pancreatic cancer	0.000944	0.00226	CcSEcCtD
Levorphanol—Pruritus—Docetaxel—pancreatic cancer	0.000933	0.00223	CcSEcCtD
Levorphanol—Agitation—Doxorubicin—pancreatic cancer	0.000927	0.00222	CcSEcCtD
Levorphanol—Dry mouth—Epirubicin—pancreatic cancer	0.000908	0.00217	CcSEcCtD
Levorphanol—Confusional state—Epirubicin—pancreatic cancer	0.000897	0.00215	CcSEcCtD
Levorphanol—Palpitations—Doxorubicin—pancreatic cancer	0.000891	0.00213	CcSEcCtD
Levorphanol—Shock—Epirubicin—pancreatic cancer	0.000875	0.0021	CcSEcCtD
Levorphanol—Convulsion—Doxorubicin—pancreatic cancer	0.000874	0.00209	CcSEcCtD
Levorphanol—Dizziness—Docetaxel—pancreatic cancer	0.000872	0.00209	CcSEcCtD
Levorphanol—Tachycardia—Epirubicin—pancreatic cancer	0.000868	0.00208	CcSEcCtD
Levorphanol—Hyperhidrosis—Epirubicin—pancreatic cancer	0.00086	0.00206	CcSEcCtD
Levorphanol—Dry mouth—Doxorubicin—pancreatic cancer	0.00084	0.00201	CcSEcCtD
Levorphanol—Vomiting—Docetaxel—pancreatic cancer	0.000839	0.00201	CcSEcCtD
Levorphanol—Rash—Docetaxel—pancreatic cancer	0.000832	0.00199	CcSEcCtD
Levorphanol—Hypotension—Epirubicin—pancreatic cancer	0.000831	0.00199	CcSEcCtD
Levorphanol—Dermatitis—Docetaxel—pancreatic cancer	0.000831	0.00199	CcSEcCtD
Levorphanol—Confusional state—Doxorubicin—pancreatic cancer	0.00083	0.00199	CcSEcCtD
Levorphanol—Shock—Doxorubicin—pancreatic cancer	0.00081	0.00194	CcSEcCtD
Levorphanol—Insomnia—Epirubicin—pancreatic cancer	0.000805	0.00193	CcSEcCtD
Levorphanol—Tachycardia—Doxorubicin—pancreatic cancer	0.000803	0.00192	CcSEcCtD
Levorphanol—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.000796	0.00191	CcSEcCtD
Levorphanol—Nausea—Docetaxel—pancreatic cancer	0.000783	0.00188	CcSEcCtD
Levorphanol—Dyspepsia—Epirubicin—pancreatic cancer	0.000783	0.00187	CcSEcCtD
Levorphanol—Hypotension—Doxorubicin—pancreatic cancer	0.000769	0.00184	CcSEcCtD
Levorphanol—Constipation—Epirubicin—pancreatic cancer	0.000761	0.00182	CcSEcCtD
Levorphanol—Insomnia—Doxorubicin—pancreatic cancer	0.000745	0.00178	CcSEcCtD
Levorphanol—Feeling abnormal—Epirubicin—pancreatic cancer	0.000733	0.00176	CcSEcCtD
Levorphanol—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000727	0.00174	CcSEcCtD
Levorphanol—Dyspepsia—Doxorubicin—pancreatic cancer	0.000725	0.00173	CcSEcCtD
Levorphanol—Urticaria—Epirubicin—pancreatic cancer	0.000707	0.00169	CcSEcCtD
Levorphanol—Constipation—Doxorubicin—pancreatic cancer	0.000704	0.00169	CcSEcCtD
Levorphanol—Abdominal pain—Epirubicin—pancreatic cancer	0.000703	0.00168	CcSEcCtD
Levorphanol—Feeling abnormal—Doxorubicin—pancreatic cancer	0.000678	0.00162	CcSEcCtD
Levorphanol—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000673	0.00161	CcSEcCtD
Levorphanol—Urticaria—Doxorubicin—pancreatic cancer	0.000654	0.00157	CcSEcCtD
Levorphanol—Abdominal pain—Doxorubicin—pancreatic cancer	0.000651	0.00156	CcSEcCtD
Levorphanol—Pruritus—Epirubicin—pancreatic cancer	0.000629	0.00151	CcSEcCtD
Levorphanol—Dizziness—Epirubicin—pancreatic cancer	0.000588	0.00141	CcSEcCtD
Levorphanol—Pruritus—Doxorubicin—pancreatic cancer	0.000582	0.00139	CcSEcCtD
Levorphanol—Vomiting—Epirubicin—pancreatic cancer	0.000566	0.00135	CcSEcCtD
Levorphanol—Rash—Epirubicin—pancreatic cancer	0.000561	0.00134	CcSEcCtD
Levorphanol—Dermatitis—Epirubicin—pancreatic cancer	0.00056	0.00134	CcSEcCtD
Levorphanol—Dizziness—Doxorubicin—pancreatic cancer	0.000544	0.0013	CcSEcCtD
Levorphanol—Nausea—Epirubicin—pancreatic cancer	0.000528	0.00127	CcSEcCtD
Levorphanol—Vomiting—Doxorubicin—pancreatic cancer	0.000523	0.00125	CcSEcCtD
Levorphanol—Rash—Doxorubicin—pancreatic cancer	0.000519	0.00124	CcSEcCtD
Levorphanol—Dermatitis—Doxorubicin—pancreatic cancer	0.000519	0.00124	CcSEcCtD
Levorphanol—Nausea—Doxorubicin—pancreatic cancer	0.000489	0.00117	CcSEcCtD
Levorphanol—OPRK1—Signaling Pathways—SSTR2—pancreatic cancer	0.000467	0.000802	CbGpPWpGaD
Levorphanol—OPRM1—GPCR downstream signaling—PTHLH—pancreatic cancer	0.000458	0.000787	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—GCG—pancreatic cancer	0.000458	0.000786	CbGpPWpGaD
Levorphanol—OPRK1—GPCR downstream signaling—CNR1—pancreatic cancer	0.000458	0.000786	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—HEY2—pancreatic cancer	0.000453	0.000778	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—CCKBR—pancreatic cancer	0.000451	0.000775	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—SST—pancreatic cancer	0.00045	0.000773	CbGpPWpGaD
Levorphanol—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCL8—pancreatic cancer	0.000449	0.000771	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—GAST—pancreatic cancer	0.000443	0.00076	CbGpPWpGaD
Levorphanol—OPRK1—GPCR downstream signaling—GCG—pancreatic cancer	0.000442	0.000759	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—SHH—pancreatic cancer	0.000439	0.000754	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—AGTR1—pancreatic cancer	0.000437	0.00075	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—IAPP—pancreatic cancer	0.000433	0.000744	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—DTX1—pancreatic cancer	0.000428	0.000735	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—SSTR3—pancreatic cancer	0.000428	0.000735	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—GLI1—pancreatic cancer	0.000424	0.000729	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—DTX4—pancreatic cancer	0.000424	0.000729	CbGpPWpGaD
Levorphanol—OPRK1—GPCR downstream signaling—AGTR1—pancreatic cancer	0.000422	0.000724	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—SCT—pancreatic cancer	0.00042	0.00072	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—HEY1—pancreatic cancer	0.00042	0.00072	CbGpPWpGaD
Levorphanol—OPRM1—GPCR downstream signaling—SST—pancreatic cancer	0.000419	0.00072	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—PTHLH—pancreatic cancer	0.000416	0.000714	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—PTCH1—pancreatic cancer	0.000416	0.000714	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—CNR1—pancreatic cancer	0.000416	0.000714	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—NRP1—pancreatic cancer	0.000413	0.000709	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—PPP2R5B—pancreatic cancer	0.000413	0.000709	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—SSTR1—pancreatic cancer	0.00041	0.000705	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—PPY—pancreatic cancer	0.000402	0.000691	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—GCG—pancreatic cancer	0.000401	0.000689	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—CCK—pancreatic cancer	0.0004	0.000687	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—HEY2—pancreatic cancer	0.000397	0.000682	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—SSTR2—pancreatic cancer	0.000395	0.000678	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—CNR2—pancreatic cancer	0.00039	0.00067	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—GLP1R—pancreatic cancer	0.00039	0.00067	CbGpPWpGaD
Levorphanol—OPRD1—GPCR ligand binding—CXCL8—pancreatic cancer	0.00039	0.000669	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—GAST—pancreatic cancer	0.000388	0.000666	CbGpPWpGaD
Levorphanol—OPRM1—GPCR downstream signaling—CNR1—pancreatic cancer	0.000387	0.000664	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—CCKAR—pancreatic cancer	0.000384	0.000659	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—AGTR1—pancreatic cancer	0.000383	0.000657	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—CCKBR—pancreatic cancer	0.000381	0.000655	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—SST—pancreatic cancer	0.000381	0.000653	CbGpPWpGaD
Levorphanol—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—pancreatic cancer	0.000379	0.000651	CbGpPWpGaD
Levorphanol—OPRM1—GPCR downstream signaling—GCG—pancreatic cancer	0.000374	0.000641	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—JAG2—pancreatic cancer	0.000372	0.000639	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—SCT—pancreatic cancer	0.000368	0.000632	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—HEY1—pancreatic cancer	0.000368	0.000632	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—MEN1—pancreatic cancer	0.000367	0.00063	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—GLI1—pancreatic cancer	0.000359	0.000616	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—DTX4—pancreatic cancer	0.000359	0.000616	CbGpPWpGaD
Levorphanol—OPRM1—GPCR downstream signaling—AGTR1—pancreatic cancer	0.000356	0.000612	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—CNR1—pancreatic cancer	0.000351	0.000603	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—CCK—pancreatic cancer	0.000351	0.000603	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—SHH—pancreatic cancer	0.00035	0.000601	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—NRP1—pancreatic cancer	0.000349	0.000599	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—PPP2R5B—pancreatic cancer	0.000349	0.000599	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—NOTCH4—pancreatic cancer	0.000348	0.000597	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—IAPP—pancreatic cancer	0.000346	0.000593	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—CNR2—pancreatic cancer	0.000342	0.000587	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—GLP1R—pancreatic cancer	0.000342	0.000587	CbGpPWpGaD
Levorphanol—OPRK1—GPCR ligand binding—CXCL8—pancreatic cancer	0.000342	0.000587	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—GCG—pancreatic cancer	0.000339	0.000582	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—CCKAR—pancreatic cancer	0.000336	0.000578	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—HEY2—pancreatic cancer	0.000336	0.000577	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—PTHLH—pancreatic cancer	0.000332	0.00057	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—PTCH1—pancreatic cancer	0.000332	0.00057	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—GAST—pancreatic cancer	0.000328	0.000563	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—JAG2—pancreatic cancer	0.000326	0.00056	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—AGTR1—pancreatic cancer	0.000324	0.000556	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—MEN1—pancreatic cancer	0.000322	0.000552	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—SCT—pancreatic cancer	0.000311	0.000534	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—HEY1—pancreatic cancer	0.000311	0.000534	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—SHH—pancreatic cancer	0.000307	0.000527	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—NOTCH4—pancreatic cancer	0.000305	0.000524	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—SST—pancreatic cancer	0.000303	0.000521	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—IAPP—pancreatic cancer	0.000303	0.00052	CbGpPWpGaD
Levorphanol—OPRD1—GPCR downstream signaling—PIK3CG—pancreatic cancer	0.000299	0.000514	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—JAG1—pancreatic cancer	0.000297	0.00051	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—CCK—pancreatic cancer	0.000297	0.000509	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—NOTCH3—pancreatic cancer	0.000296	0.000508	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—PTHLH—pancreatic cancer	0.000291	0.000499	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—PTCH1—pancreatic cancer	0.000291	0.000499	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—CNR2—pancreatic cancer	0.000289	0.000496	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—GLP1R—pancreatic cancer	0.000289	0.000496	CbGpPWpGaD
Levorphanol—OPRM1—GPCR ligand binding—CXCL8—pancreatic cancer	0.000289	0.000496	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—CCKAR—pancreatic cancer	0.000284	0.000488	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—CNR1—pancreatic cancer	0.00028	0.000481	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—JAG2—pancreatic cancer	0.000276	0.000474	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—MEN1—pancreatic cancer	0.000272	0.000467	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—PIK3CG—pancreatic cancer	0.000272	0.000467	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—GCG—pancreatic cancer	0.00027	0.000464	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—SST—pancreatic cancer	0.000266	0.000457	CbGpPWpGaD
Levorphanol—OPRD1—GPCR downstream signaling—PIK3CD—pancreatic cancer	0.000263	0.000452	CbGpPWpGaD
Levorphanol—OPRK1—GPCR downstream signaling—PIK3CG—pancreatic cancer	0.000262	0.00045	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—JAG1—pancreatic cancer	0.00026	0.000447	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—SHH—pancreatic cancer	0.000259	0.000445	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—NOTCH3—pancreatic cancer	0.000259	0.000445	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—AGTR1—pancreatic cancer	0.000258	0.000443	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—NOTCH4—pancreatic cancer	0.000258	0.000442	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—IAPP—pancreatic cancer	0.000256	0.00044	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—STK11—pancreatic cancer	0.000254	0.000437	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—PTHLH—pancreatic cancer	0.000246	0.000422	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—PTCH1—pancreatic cancer	0.000246	0.000422	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—CNR1—pancreatic cancer	0.000245	0.000422	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—PIK3CD—pancreatic cancer	0.000239	0.00041	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—PIK3CG—pancreatic cancer	0.000238	0.000409	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—GCG—pancreatic cancer	0.000237	0.000407	CbGpPWpGaD
Levorphanol—OPRK1—GPCR downstream signaling—PIK3CD—pancreatic cancer	0.000231	0.000396	CbGpPWpGaD
Levorphanol—OPRD1—GPCR downstream signaling—PIK3CB—pancreatic cancer	0.000229	0.000394	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—AGTR1—pancreatic cancer	0.000226	0.000388	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—SST—pancreatic cancer	0.000225	0.000386	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—STK11—pancreatic cancer	0.000223	0.000383	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—SMAD4—pancreatic cancer	0.000223	0.000382	CbGpPWpGaD
Levorphanol—OPRM1—GPCR downstream signaling—PIK3CG—pancreatic cancer	0.000222	0.000381	CbGpPWpGaD
Levorphanol—OPRD1—GPCR downstream signaling—CXCL8—pancreatic cancer	0.00022	0.000378	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—JAG1—pancreatic cancer	0.00022	0.000378	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—NOTCH3—pancreatic cancer	0.000219	0.000376	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—HES1—pancreatic cancer	0.000217	0.000373	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—PIK3CD—pancreatic cancer	0.000209	0.00036	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—PIK3CB—pancreatic cancer	0.000208	0.000357	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—CNR1—pancreatic cancer	0.000207	0.000356	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—PIK3CG—pancreatic cancer	0.000201	0.000346	CbGpPWpGaD
Levorphanol—OPRK1—GPCR downstream signaling—PIK3CB—pancreatic cancer	0.000201	0.000345	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—GCG—pancreatic cancer	0.0002	0.000344	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—CXCL8—pancreatic cancer	0.0002	0.000344	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—SMAD4—pancreatic cancer	0.000195	0.000335	CbGpPWpGaD
Levorphanol—OPRM1—GPCR downstream signaling—PIK3CD—pancreatic cancer	0.000195	0.000335	CbGpPWpGaD
Levorphanol—OPRK1—GPCR downstream signaling—CXCL8—pancreatic cancer	0.000193	0.000332	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—AGTR1—pancreatic cancer	0.000191	0.000328	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—HES1—pancreatic cancer	0.000191	0.000327	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—TERT—pancreatic cancer	0.00019	0.000327	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—STK11—pancreatic cancer	0.000188	0.000324	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—PIK3CB—pancreatic cancer	0.000183	0.000313	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—HIF1A—pancreatic cancer	0.000182	0.000313	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—TSC2—pancreatic cancer	0.000182	0.000312	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—APOE—pancreatic cancer	0.000178	0.000305	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—PIK3CD—pancreatic cancer	0.000177	0.000304	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—CXCL8—pancreatic cancer	0.000175	0.000301	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—KDR—pancreatic cancer	0.000174	0.000299	CbGpPWpGaD
Levorphanol—OPRM1—GPCR downstream signaling—PIK3CB—pancreatic cancer	0.00017	0.000292	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—TERT—pancreatic cancer	0.000167	0.000287	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—NFKBIA—pancreatic cancer	0.000166	0.000285	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—SMAD4—pancreatic cancer	0.000165	0.000283	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—NOTCH1—pancreatic cancer	0.000164	0.000282	CbGpPWpGaD
Levorphanol—OPRM1—GPCR downstream signaling—CXCL8—pancreatic cancer	0.000163	0.00028	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—HES1—pancreatic cancer	0.000161	0.000277	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—PIK3CG—pancreatic cancer	0.00016	0.000276	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—NRAS—pancreatic cancer	0.00016	0.000276	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—HIF1A—pancreatic cancer	0.00016	0.000274	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—TSC2—pancreatic cancer	0.000159	0.000274	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—EGF—pancreatic cancer	0.000159	0.000272	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—APOE—pancreatic cancer	0.000156	0.000268	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—PIK3CB—pancreatic cancer	0.000154	0.000265	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—KDR—pancreatic cancer	0.000153	0.000262	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—CXCL8—pancreatic cancer	0.000148	0.000255	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—EGFR—pancreatic cancer	0.000146	0.000251	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—NFKBIA—pancreatic cancer	0.000145	0.00025	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—NOTCH1—pancreatic cancer	0.000144	0.000247	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—TERT—pancreatic cancer	0.000141	0.000242	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—PIK3CD—pancreatic cancer	0.000141	0.000242	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—PIK3CG—pancreatic cancer	0.000141	0.000242	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—NRAS—pancreatic cancer	0.000141	0.000242	CbGpPWpGaD
Levorphanol—OPRD1—GPCR downstream signaling—PIK3CA—pancreatic cancer	0.00014	0.00024	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—EGF—pancreatic cancer	0.000139	0.000239	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—KRAS—pancreatic cancer	0.000138	0.000237	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—HIF1A—pancreatic cancer	0.000135	0.000232	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—TSC2—pancreatic cancer	0.000135	0.000231	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—APOE—pancreatic cancer	0.000132	0.000226	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—KDR—pancreatic cancer	0.000129	0.000222	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—EGFR—pancreatic cancer	0.000128	0.00022	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—PIK3CA—pancreatic cancer	0.000127	0.000218	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—PIK3CD—pancreatic cancer	0.000124	0.000212	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—PIK3CB—pancreatic cancer	0.000123	0.000211	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—NFKBIA—pancreatic cancer	0.000123	0.000211	CbGpPWpGaD
Levorphanol—OPRK1—GPCR downstream signaling—PIK3CA—pancreatic cancer	0.000123	0.00021	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—NOTCH1—pancreatic cancer	0.000122	0.000209	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—KRAS—pancreatic cancer	0.000121	0.000208	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—PIK3CG—pancreatic cancer	0.000119	0.000204	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—NRAS—pancreatic cancer	0.000119	0.000204	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—CXCL8—pancreatic cancer	0.000118	0.000203	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—EGF—pancreatic cancer	0.000118	0.000202	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—HRAS—pancreatic cancer	0.000117	0.000202	CbGpPWpGaD
Levorphanol—OPRD1—GPCR downstream signaling—AKT1—pancreatic cancer	0.000114	0.000196	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—CASP3—pancreatic cancer	0.000113	0.000194	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—PIK3CA—pancreatic cancer	0.000111	0.000191	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—CCND1—pancreatic cancer	0.00011	0.000189	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—CTNNB1—pancreatic cancer	0.000109	0.000187	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—EGFR—pancreatic cancer	0.000108	0.000186	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—PIK3CB—pancreatic cancer	0.000108	0.000185	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—MMP9—pancreatic cancer	0.000107	0.000184	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—PTEN—pancreatic cancer	0.000106	0.000182	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—PIK3CD—pancreatic cancer	0.000105	0.00018	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—AKT1—pancreatic cancer	0.000104	0.000178	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—CXCL8—pancreatic cancer	0.000104	0.000178	CbGpPWpGaD
Levorphanol—OPRM1—GPCR downstream signaling—PIK3CA—pancreatic cancer	0.000104	0.000178	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—HRAS—pancreatic cancer	0.000103	0.000177	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—KRAS—pancreatic cancer	0.000102	0.000176	CbGpPWpGaD
Levorphanol—OPRK1—GPCR downstream signaling—AKT1—pancreatic cancer	0.0001	0.000172	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—CASP3—pancreatic cancer	9.92e-05	0.00017	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—SRC—pancreatic cancer	9.86e-05	0.000169	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—CCND1—pancreatic cancer	9.65e-05	0.000166	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—VEGFA—pancreatic cancer	9.6e-05	0.000165	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—CTNNB1—pancreatic cancer	9.56e-05	0.000164	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—STAT3—pancreatic cancer	9.5e-05	0.000163	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—NRAS—pancreatic cancer	9.48e-05	0.000163	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—PIK3CA—pancreatic cancer	9.4e-05	0.000162	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—MMP9—pancreatic cancer	9.37e-05	0.000161	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—PTEN—pancreatic cancer	9.32e-05	0.00016	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—PIK3CB—pancreatic cancer	9.11e-05	0.000157	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—AKT1—pancreatic cancer	9.09e-05	0.000156	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—MYC—pancreatic cancer	8.83e-05	0.000152	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—TGFB1—pancreatic cancer	8.81e-05	0.000151	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—CXCL8—pancreatic cancer	8.76e-05	0.00015	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—HRAS—pancreatic cancer	8.7e-05	0.000149	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—SRC—pancreatic cancer	8.64e-05	0.000148	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—EGFR—pancreatic cancer	8.64e-05	0.000148	CbGpPWpGaD
Levorphanol—OPRM1—GPCR downstream signaling—AKT1—pancreatic cancer	8.46e-05	0.000145	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—VEGFA—pancreatic cancer	8.42e-05	0.000145	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—CASP3—pancreatic cancer	8.38e-05	0.000144	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—STAT3—pancreatic cancer	8.33e-05	0.000143	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—NRAS—pancreatic cancer	8.31e-05	0.000143	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—KRAS—pancreatic cancer	8.16e-05	0.00014	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—CCND1—pancreatic cancer	8.16e-05	0.00014	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—CTNNB1—pancreatic cancer	8.08e-05	0.000139	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—MMP9—pancreatic cancer	7.92e-05	0.000136	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—PTEN—pancreatic cancer	7.88e-05	0.000135	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—MYC—pancreatic cancer	7.74e-05	0.000133	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—TGFB1—pancreatic cancer	7.72e-05	0.000133	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—AKT1—pancreatic cancer	7.68e-05	0.000132	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—EGFR—pancreatic cancer	7.57e-05	0.00013	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—PIK3CA—pancreatic cancer	7.5e-05	0.000129	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—SRC—pancreatic cancer	7.3e-05	0.000125	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—TP53—pancreatic cancer	7.25e-05	0.000125	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—KRAS—pancreatic cancer	7.16e-05	0.000123	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—VEGFA—pancreatic cancer	7.11e-05	0.000122	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—STAT3—pancreatic cancer	7.04e-05	0.000121	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—NRAS—pancreatic cancer	7.03e-05	0.000121	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—HRAS—pancreatic cancer	6.94e-05	0.000119	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—PIK3CA—pancreatic cancer	6.57e-05	0.000113	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—MYC—pancreatic cancer	6.54e-05	0.000112	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—TGFB1—pancreatic cancer	6.53e-05	0.000112	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—EGFR—pancreatic cancer	6.4e-05	0.00011	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—TP53—pancreatic cancer	6.36e-05	0.000109	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—AKT1—pancreatic cancer	6.12e-05	0.000105	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—HRAS—pancreatic cancer	6.08e-05	0.000104	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—KRAS—pancreatic cancer	6.05e-05	0.000104	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—PIK3CA—pancreatic cancer	5.56e-05	9.54e-05	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—TP53—pancreatic cancer	5.37e-05	9.23e-05	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—AKT1—pancreatic cancer	5.37e-05	9.22e-05	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—HRAS—pancreatic cancer	5.14e-05	8.83e-05	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—AKT1—pancreatic cancer	4.54e-05	7.79e-05	CbGpPWpGaD
